Author's posts
How Much Will A Covid-19 Vaccine Cost?
As Pfizer and Moderna edge closer to regulatory approval, access—and herd immunity—hinges on affordability.
Pfizer Has A Head Start, But The Covid-19 Vaccine Market Is Still Up For Grabs
Any first-mover advantage won’t last long, as some vaccine candidates may be easier to transport and administer than others.
Amwell Launches New Products As It Posts First Earnings Since IPO
The Boston-based telehealth company beat revenue expectations but missed on earnings per share.
Georgia Requires Signature Matching On Mail-In Ballots, But The Science Is Dubious
Thirty-one states, including Georgia, have signature matching requirements to verify absentee ballots, but it’s hard to find an objective way to do it.
There Is No Silver Bullet Coronavirus Test, But Here’s How Diagnostics Can Help
The White House outbreaks illustrate the limits of what Covid-19 diagnostics can and can’t tell us, and why different types of tests are needed to help control infection spread.
How Human Genome Sequencing Went From $1 Billion A Pop To Under $1,000
On the 30th anniversary of the Human Genome Project, leading genomicist and director of the ongoing federal research effort Dr. Eric Green reflects on how far we’ve come and what the future holds.
Merck CEO Ken Frazier Calls On Corporate America To Help Stabilize Society
Frazier says companies should lobby for better education, healthcare and social justice, just like they lobby for business interests.
Side Effects From Chemo Can Be Devastating. This Startup Aims To Change That.
Shasqi is the first of 300 healthcare companies backed by Y Combinator to start clinical trials in humans, with a plan to make chemo a better experience with more targeted therapy.
Digital Health Startup Raises $12 Million To Provide Virtual OCD Treatment
Founder and CEO Stephen Smith launched NOCD after his own struggle getting diagnosed and treated.
This AI Startup Helps Hospitals Navigate Operational Troubles Of Covid-19 And Beyond
Qventus expects to hit $18 million in revenue by the end of the year, a 50% increase from 2019.
